Evidence map›Paper›PMID 15254245›Full record

ArticleMolecular and cellular biology2004

RACK1 regulates G1/S progression by suppressing Src kinase activity.

Vidya Mamidipudi, Jian Zhang, Kelly C Lee, Christine A Cartwright

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Rack1 maintains intestinal homeostasis by protecting the integrity of the epithelial barrier.American journal of physiology. Gastrointestinal and liver physiology · 2018
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Structure of human Rack1 protein at a resolution of 2.45 Å.Acta crystallographica. Section F, Structural biology and crystallization communications · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Vidya MamidipudiStanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305-5187, USA.
Jian Zhang
Kelly C Lee
Christine A Cartwright
Stanford University · US

Funding

INTESTINAL CELL GROWTH CONTROL: ROLE OF TYROSINE KINASESR01DK043743 · NIDDK · STANFORD UNIVERSITY · PI CARTWRIGHT, CHRISTINE ANN · 1996 to 2015
$4.3M
INTESTINAL CELL GROWTH CONTROL--ROLE OF TYROSINE KINASER29DK043743 · NIDDK · STANFORD UNIVERSITY · PI CARTWRIGHT, CHRISTINE ANN · 1991 to 1995
–
NIDDK NIH HHS DK 43743NIDDK NIH HHS R01 DK043743
6 · The paper itself

Abstract

Cancer genes exert their greatest influence on the cell cycle by targeting regulators of a critical checkpoint in late G(1). Once cells pass this checkpoint, they are fated to replicate DNA and divide. Cancer cells subvert controls at work at this restriction point and remain in cycle. Previously, we showed that RACK1 inhibits the oncogenic Src tyrosine kinase and NIH 3T3 cell growth. RACK1 inhibits cell growth, in part, by prolonging G(0)/G(1). Here we show that RACK1 overexpression induces a partial G(1) arrest by suppressing Src activity at the G(1) checkpoint. RACK1 works through Src to inhibit Vav2, Rho GTPases, Stat3, and Myc. Consequently, cyclin D1 and cyclin-dependent kinases 4 and 2 (CDK4 and CDK2, respectively) are suppressed, CDK inhibitor p27 and retinoblastoma protein are activated, E2F1 is sequestered, and G(1)/S progression is delayed. Conversely, downregulation of RACK1 by short interference RNA activates Src-mediated signaling, induces Myc and cyclin D1, and accelerates G(1)/S progression. RACK1 suppresses Src- but not mitogen-activated protein kinase-dependent platelet-derived growth factor signaling. We also show that Stat3 is required for Rac1 induction of Myc. Our results reveal a novel mechanism of cell cycle control in late G(1) that works via an endogenous inhibitor of the Src kinase.

Indexed as

G1 PhaseMuscle ProteinsProto-Oncogene ProteinsS PhaseAnimalsCDC2-CDC28 KinasesCell CycleCell DivisionCyclin D1Cyclin-Dependent Kinase 2Cyclin-Dependent Kinase 4Cyclin-Dependent KinasesFlow CytometryGenes, ReporterGTP-Binding ProteinsHumansCDC2-CDC28 KinasesCDK2 protein, humanCdk2 protein, mouseCDK4 protein, humanCdk4 protein, mouseCyclin D1Cyclin-Dependent Kinase 2Cyclin-Dependent Kinase 4Cyclin-Dependent KinasesGTP-Binding ProteinsMicrofilament ProteinsMitogen-Activated Protein KinasesMuscle ProteinsNeoplasm ProteinsOncogene ProteinsProto-Oncogene ProteinsProto-Oncogene Proteins c-mycProto-Oncogene Proteins c-vavRACK1 protein, humanReceptors, Cell SurfaceReceptors for Activated C KinaseRetinoblastoma Proteinsrc-Family KinasesTagln protein, mouseVAV2 protein, humanVav2 protein, mouse

Identifiers

PMID15254245
PMCPMC444846
OpenAlexW2126902762

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.